Moraxella catarrhalis strains with reduced expression of the UspA outer membrane proteins belong to a distinct subpopulation. (Q54678435)

2 June 2018

title

Moraxella catarrhalis strains with reduced expression of the UspA outer membrane proteins belong to a distinct subpopulation. (English)

1 reference

2 June 2018

1 reference

Moraxella catarrhalis

object named as

Moraxella catarrhalis

1 reference

inferred from title

author name string

Patricia Stutzmann Meier

1

1 reference

2 June 2018

Rolf Troller

2

1 reference

2 June 2018

Nadja Heiniger

3

1 reference

2 June 2018

Ioanna N Grivea

4

1 reference

2 June 2018

George A Syrogiannopoulos

5

1 reference

2 June 2018

Christoph Aebi

6

1 reference

2 June 2018

language of work or name

English

0 references

publication date

1 March 2005

1 reference

2 June 2018

published in

Vaccine

1 reference

2 June 2018

volume

23

1 reference

2 June 2018

issue

16

1 reference

2 June 2018

page(s)

2000-2008

1 reference

2 June 2018

Microbiology of otitis media in the Paris, France, area from 1987 to 1997

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Quantitative cultures of middle-ear fluid in acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Lung infections. 2. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Vaccines for Moraxella catarrhalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Immune response to surface protein A of Streptococcus pneumoniae and to high-molecular-weight outer membrane protein A of Moraxella catarrhalis in children with acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

A Large, Antigenically Conserved Protein On The Surface Of Moraxella Catarrhalis Is A Target For Protective Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Expression of the Moraxella catarrhalis UspA1 protein undergoes phase variation and is regulated at the transcriptional level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Phase variation of HpuAB and HmbR, two distinct haemoglobin receptors of Neisseria meningitidis DNM2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Multiple mechanisms of phase variation of PorA in Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Variation in expression of class 1 and class 5 outer membrane proteins during nasopharyngeal carriage of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

7 January 2021

Branhamella catarrhalis respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

7 January 2021

Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

7 January 2021

Antigenic diversity and gene polymorphisms in Haemophilus influenzae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.036

7 January 2021

10.1016/J.VACCINE.2004.09.036

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018